Filing Details
- Accession Number:
- 0001140361-23-057880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-15 16:07:10
- Reporting Period:
- 2023-12-13
- Accepted Time:
- 2023-12-15 16:07:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1801993 | C. Sean Flynn | 64 Sidney Street Cambridge MA 02139 | Svp, General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-12-13 | 1,432 | $34.20 | 4,573 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-12-14 | 106 | $37.45 | 4,467 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).